SOLYSTAT

Google image searchProduct monograph

Active ingredient

sodium polystyrene sulfonate, 250 MG/ML

DIN: 00769541

Dosage form(s): SUSPENSION

Route(s) of administration: ORAL

Schedule: Prescription

Company: PENDOPHARM DIVISION OF PHARMASCIENCE INC

Date: 19-JUN-2012

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
• V03AE01 — POLYSTYRENE SULPHONATE (ATC/DDD)

Reference brand drug: Kayexalate

Pharmaceutical standard: USP

External Links for Solystat

Search on Google

• Solystat side effects
• Solystat dosage
• sodium polystyrene sulfonate side effects
• sodium polystyrene sulfonate dosage